Support for Strawman Solution and Limited Preventative Registration
Dear Sir / Madam, Merck KGaA is applicant for .merck and .emerck gTLDs. Merck KGaA actively defends its trademark portfolio against domain name abuse and actively fights counterfeiting activities in the field of illegal drug sales. Among other measures Merck KGaA sent numerous cease and desist letters and filed UDRP proceedings against bad faith domain name registrations of our valuable brands. Merck KGaA is convinced that the proposed "Strawman Solution" and the "Limited Preventative Registration" will be effectively support our efforts in increasing the online safety for our consumers and patients worldwide. We therefore support adoption of both proposals. Merck KGaA believes these enhancements should be implemented so ICANN’s underlying new gTLD policy of Protecting the Rights of Others can be achieved - given the breadth, scale and scope of the proposed expansion of the Domain Name System, especially as we expect an increase of online infringement within the new gTLD space. Thank you for your consideration. Best regards, _________________________________ Jonas Kölle Director Rechtsanwalt / Senior Corporate Counsel Merck KGaA Corporate Trademarks Frankfurter Straße 250 D- 64293 Darmstadt - Germany - mailto: jonas.koelle@xxxxxxxxxxxxxx Phone: + 49 - 6151- 72 - 5303 Fax: + 49 - 6151 - 72 - 3378 Pflichtangaben finden Sie unter http://www.merckgroup.com/mandatories Mandatory Information can be found at http://www.merckgroup.com/mandatories This message and any attachment are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient, you must not copy this message or attachment or disclose the contents to any other person. If you have received this transmission in error, please notify the sender immediately and delete the message and any attachment from your system. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not accept liability for any omissions or errors in this message which may arise as a result of E-Mail-transmission or for damages resulting from any unauthorized changes of the content of this message and any attachment thereto. Merck KGaA, Darmstadt, Germany and any of its subsidiaries do not guarantee that this message is free of viruses and does not accept liability for any damages caused by any virus transmitted therewith. Click http://www.merckgroup.com/disclaimer to access the German, French, Spanish and Portuguese versions of this disclaimer.